Dr. Emad Bashier Ibrahim Elmagboul
Senior Consultant and associate professor, HMC
Dr. Emad Ibrahim obtained his FRCPath from the Royal College of Pathologists in London. He is the head of Clinical Microbiology & Virology division at HMC, Chairperson of the Infection Prevention and Control in the Heart Hospital, and country advisor for the Royal College of Pathologists. He is the head of Quality Cluster and lead quality and infection control teams during the JCI and CAP inspection and other quality activities.
Dr. Ibrahim worked as a clinical consultant microbiologist and virologist at different hospitals in the UK including Southmead, Frenchay, Bristol Royal Infirmary, Western Supermare and Ealing Hospital in London. His roles encompassed direct clinical care as well as laboratory management, health protection, protocol and guidance development, infection control and training supervision.
His research interests are multidisciplinary with emphasis on diagnostic approaches, epidemiology, antimicrobial susceptibility and resistance and infection control. Research Interests include development and evaluation of rapid and molecular techniques for diagnosis of signification infections. He studied the clinical utility and clinical relevance of a positive molecular test (Cepheid Xpert) in the diagnosis of Clostridium difficile infection and the impact of introducing molecular diagnosis of Clostridium. Most recently he participated in publishing a study using real time multiplex PCR for identification of enteric pathogens and whole genome sequencing for detection resistance among MDRO Pseudomonas and detecting MRC genes responsible for colistin resistance.
Additional to chairing he is an active member of several local, corporate and national committees. He is a focal point for WHO Global Antimicrobial Resistance Surveillance System (GLASS).
Currently he is associate professor at the Biomedical Research Center at Qatar University, assistant professor at Weill Cornell Medical College and previously he was a lecturer at the School of Cellular and Molecular Medicine-University of Bristol.
